N/A N=20 Treatment

Penile Nerve Stimulation for Treatment of Delayed Ejaculation

Delayed Ejaculation

Bottom Line

View on ClinicalTrials.gov: NCT04115540 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2025

Primary outcome: Primary: International Index of Erectile Function (IIEF) Scale Score — 7.5; 9.7 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: TENS penile nerve stimulation (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: Male
Sponsor: Stanford University
Primary completion: Jan 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY International Index of Erectile Function (IIEF) Scale Score	7.5; 9.7	—
SECONDARY Count of Participants With Treatment-related Adverse Events as Assessed by Survey	—	—

Summary

The aim of this clinical trial is to test the safety and feasibility of using transcutaneous electrical nerve stimulation (TENS) of the penile nerves to reduce intra-vaginal ejaculatory latency time in men with delayed ejaculation (DE). We hypothesize that this type of stimulation, either before or during sexual activity, will reduce latency time. The primary objective of this study is to determine if TENS of the penile nerve helps men with DE subjectively reduce their ejaculatory latency time. The secondary objective is to determine whether their International Index of Erectile Function (IIEF) score improves with treatment.

Eligibility Criteria

Inclusion Criteria

18 years or older
Sexually active
Diagnosed with delayed ejaculation

Exclusion Criteria

Less than 18 years old
Any condition effecting the participant that would make them unable to operate the interventional device

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04115540). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.